Open Access

Q&A - Challenging the current treatment paradigm - SGLT2 inhibition in heart failure.

logo

Congress Presentation

About the speakers

Professor Marco Metra

University of Brescia, Brescia (Italy)
140 presentations
31 followers

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
83 presentations
12 followers

4 more presentations in this session

Chair’s introduction - Challenging the current treatment paradigm - SGLT2 inhibition in heart failure.

Speaker: Professor M. Metra (Brescia, IT)

Thumbnail

The ongoing problem of heart failure.

Speaker: Professor K. Ray (London, GB)

Thumbnail

SGLT2 inhibition: the potential to change the heart failure landscape?

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

Summary & close - Challenging the current treatment paradigm - SGLT2 inhibition in heart failure.

Speaker: Professor M. Metra (Brescia, IT)

Thumbnail

Access the full session

Challenging the current treatment paradigm - SGLT2 inhibition in heart failure (EBAC Accredited)

Speakers: Professor M. Metra, Professor K. Ray, Professor M. Metra, Professor K. Ray, Professor J. McMurray...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by